Morning Overview on MSN

Eli Lilly’s new Zepbound pen packs a full month of obesity doses

Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a ...
Healio

FDA approves label expansion for Zepbound to be used with Eli Lilly’s KwikPen

The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...